Health Equity Ventures

Health Equity Ventures Research

Investment Thesis

Health Equity Ventures is a pioneering, double bottom-line venture capital firm dedicated to advancing health equity for diverse and underserved populations. Founded in 2019 and headquartered in Oakland, California, the firm combines financial returns with meaningful social impact. Their central investment thesis is that the future of healthcare innovation must address and eliminate healthcare disparities—focusing not just on technological advancement, but on ensuring that solutions are accessible, affordable, and beneficial to marginalized communities.

The firm operates with a clear mission: to identify and support innovative healthcare solutions that improve health outcomes for vulnerable and underserved populations. Rather than pursuing general healthcare innovation, Health Equity Ventures deliberately filters every investment through a health equity lens, asking whether a company's solution meaningfully addresses barriers to healthcare access and reduces inequality.

Sector and Market Focus

Health Equity Ventures invests exclusively in the healthcare industry, with particular emphasis on:

Healthcare Equity & Access:

• Digital health and telehealth solutions serving underserved populations
• Healthcare technology addressing healthcare disparities
• Solutions improving access to care for marginalized communities
• Technologies serving low-income, minority, and vulnerable populations

Solution Types:

• Clinical decision support and diagnostic tools for safety-net healthcare
• Data analytics and health IT improving equity outcomes
• Patient engagement and adherence solutions
• Community health worker technology platforms
• Maternal and reproductive health equity solutions
• Mental health and behavioral health equity solutions

Disease and Condition Focus:

• Chronic disease management in underserved communities
• Maternal and child health equity
• Mental health and substance use disorder treatment
• Primary care enhancement for underserved populations

The firm explicitly avoids pure medical device hardware, specialty pharmaceuticals without equity focus, and healthcare solutions that do not serve diverse or underserved populations.

Stage Focus and Check Size

Health Equity Ventures is an early-stage specialist focused on the critical seed and pre-seed phase:

Typical Investment Stages:

• Pre-Seed: $100K - $250K (for teams with problem validation)
• Seed: $250K - $500K (for teams with product-market validation in underserved markets)
• Occasional Series A: Up to $500K (selective follow-ons for exceptional portfolio companies)

Check Size Range: $100,000 - $500,000 Target Ownership: 10-15% for seed investments

The firm positions itself as an "on-ramp" for founders building health equity solutions who might otherwise struggle to access institutional capital—particularly founders from underrepresented backgrounds, diverse founders, and those with deep lived experience in underserved communities.

Investment Activity & Recent Momentum

Health Equity Ventures has been actively investing since 2019 and has successfully executed over 30 investments in the healthcare sector. The firm demonstrates consistent activity in its focus area, with emphasis on:

Recent Investment Patterns:

• Regular pre-seed and seed investments in health equity-focused startups
• Active portfolio support and hands-on mentorship
• Partnerships with strategic LPs including the American Hospital Association, Advocate Health Care, Eli Lilly, HCA Healthcare, Henry Ford Health System, and LHC Group
• Engagement with innovation challenges and incubator programs

Fund Status: Actively deploying capital and identifying new investment opportunities in health equity innovation

Notable Recent Engagements:

• Involvement in remote patient monitoring innovation challenges (2020)
• Participation in digital health equity conversations and summits (2021-present)
• Strategic partnerships advancing equitable healthcare innovation

Team and Leadership

Dr. Michael L. Penn Jr. - Founding Partner & Managing Director

• MD, PhD with extensive background in healthcare and health equity
• Recognized thought leader on equity-driven healthcare innovation
• Serves as advisor to the American Medical Association on health equity in innovation
• Deep expertise in healthcare disparities and solutions for underserved communities
• Active advisor and board member across health equity organizations

Jocelyne C. Penn - Partner

• MBA from UCLA (2000) with degrees in social anthropology and political science
• 20+ years of experience in commercial strategy and healthcare leadership across:
  • Eli Lilly (pharmaceutical company)
  • Medtronic (medical device leader)
  • Boston Scientific (medical device/healthcare)
  • Multiple health-focused startups in data analytics and telehealth SaaS
• Deep expertise in business development, clinical advisory, go-to-market strategy
• Special education advocate and community board member
• Brings unique perspective on healthcare inequities and solutions for vulnerable populations

Collective Expertise:

• Provider organization perspective (health systems, safety-net providers)
• Payer perspective (insurance and healthcare delivery)
• Manufacturer perspective (life sciences, medical devices, pharmaceuticals)
• Healthcare startup and scaling experience
• Operator-first investment philosophy with hands-on mentorship

Decision Process and Investment Philosophy

Decision Structure: Partnership-driven

• Michael and Jocelyne jointly evaluate investments
• Collaborative approach with portfolio company operators
• Engagement with clinical and community advisors for validation

Decision Timeline: Typically 4-8 weeks for pre-seed/seed investments Warm Introductions: Preferred but not absolute requirement for compelling founders and solutions

Investment Philosophy:

• Operator-first: Hands-on management and strategic guidance for portfolio companies
• Mission-aligned: Deep commitment to health equity outcomes beyond financial returns
• Founder-focused: Particular interest in underrepresented and diverse founders
• Evidence-driven: Emphasis on data supporting health equity impact claims
• Realistic equity lens: Understanding that health equity solutions must also achieve commercial viability

Portfolio Approach and Value-Add

Beyond capital, Health Equity Ventures provides:

1. Strategic Guidance: Commercialization strategy for equity-focused healthcare solutions
2. Stakeholder Access: Connections to health systems, payers, community organizations
3. Clinical Expertise: Access to clinical advisors and health equity specialists
4. Go-to-Market Support: Assistance navigating healthcare sales and adoption
5. Founder Support: Mentorship for diverse and early-stage founders entering healthcare
6. Network: Introduction to co-investors, strategic partners, and customers

Geographic and Demographic Focus

Primary Investment Geography: United States, with emphasis on:

• Communities with significant healthcare disparities
• Rural and underserved urban areas
• Safety-net healthcare systems

Founder Preferences:

• Founders from underrepresented backgrounds in venture capital
• Founders with lived experience serving underserved communities
• First-time entrepreneurs with deep domain expertise
• Diverse founding teams reflecting the communities they serve

Competitive Landscape and Differentiation

Health Equity Ventures operates in a growing but still small ecosystem of health equity-focused investors. Key differentiators include:

• Pure health equity focus: Unlike general healthcare VCs, every investment filters through equity lens
• Early-stage specialization: Focused on pre-seed/seed, not later-stage or broad healthcare
• Founder diversity: Explicit commitment to backing diverse and underrepresented founders
• Operational depth: Deep healthcare experience across provider, payer, manufacturer, and startup sides
• Mission commitment: Truly dual-bottom-line approach (financial + health equity impact)

Co-Investors and Ecosystem

Health Equity Ventures works with:

• Large healthcare provider organizations (American Hospital Association, Advocate Health Care, HCA Healthcare, Henry Ford Health System)
• Life sciences companies (Eli Lilly, others)
• Healthcare focused nonprofits and foundations
• Regional Bay Area venture investors
• Impact-focused investors aligned with health equity mission

Notable Examples and Impact

The firm has demonstrated:

• Over 30 healthcare investments since 2019
• Involvement in remote patient monitoring and digital health challenges
• Support for diverse founders building equity-focused solutions
• Strategic partnerships with major healthcare stakeholders
• Growing recognition in health equity and digital health communities

Investment Decision Criteria

Health Equity Ventures evaluates opportunities based on:

1. Clear Health Equity Impact: Does the solution meaningfully address healthcare disparities?
2. Underserved Market Focus: Does it serve a population facing healthcare access barriers?
3. Founder Quality: Does the team have relevant healthcare expertise or lived experience?
4. Product-Market Fit: Is there evidence of solution-market fit in the target community?
5. Commercial Viability: Can this achieve financial success while serving underserved populations?
6. Scalability: Does the solution have potential to reach meaningful scale?
7. Founder Diversity: Preference for underrepresented and diverse founders

Geographic and Operational Headquarters

• Address: 66 Franklin Street, Suite 300, Oakland, California
• Region: San Francisco Bay Area / East Bay
• Primary Contact: [email protected]